BETHANY BAIRD: Open Payments
NPI 1306481031 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,210 in 196 payments from 33 companies in 2025. Trend: 2023 $885 · 2024 $1,861 · 2025 $3,210
Food & beverage: $3,210
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 87 | $1,017 |
| AstraZeneca Pharmaceuticals LP | 11 | $231 |
| Novartis Pharmaceuticals Corporation | 11 | $197 |
| SOBI, INC | 11 | $174 |
| PFIZER INC. | 11 | $140 |
| Incyte Corporation | 5 | $123 |
| BeOne Medicines USA, Inc. | 7 | $118 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| ABBVIE INC. | 4 | $95 |
| Exelixis Inc. | 4 | $86 |
Products named: Enhertu, DATROWAY, IMFINZI, Doptelet, KISQALI, BRUKINSA, JAKAFI, EPKINLY.
Industry payments across NV — which companies pay providers there.
